Suchergebnisse - "Glioma"

PubPharm (39.696)

61

A comparative study of diffusion kurtosis imaging and diffusion tensor imaging in detecting corticospinal tract impairment in diffuse glioma patients

enthalten in: Neuroradiology | 2024

von Liu, X. | Zeng, S. | Tao, T. | +4

62

Is proton beam therapy always better than photon irradiation? Lessons from two cases

enthalten in: Journal of medical radiation sciences | 2024

von Li, M. | Yeo, A. | Gunewardena, R. | +6

63

Noninvasive- and invasive mapping reveals similar language network centralities - A function-based connectome analysis

enthalten in: Cortex; a journal devoted to the study of the nervous system and behavior | 2024

von Ille, S. | Zhang, H. | Stassen, N. | +5

64

EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization

enthalten in: Journal of neuropathology and experimental neurology | 2024

von Wilcock, D. | Goold, E. | Zuromski, L. | +3

65

Improvement of diffusion tensor imaging-based tractography by free-water correction in nonedematous gliomas : assessment with brain mapping

enthalten in: Journal of neurosurgery | 2024

von Almairac, F. | Parker, D. | Mondot, L. | +5

66

The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions

enthalten in: European journal of nuclear medicine and molecular imaging | 2024

von Zinsz, A. | Pouget, C. | Rech, F. | +6

67

E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability

enthalten in: Cancer letters | 2024

von Jiang, X. | You, H. | Niu, Y. | +12

68

Glioma Stem Cells-Features for New Therapy Design

enthalten in: Cancers | 2024

von Pećina-Šlaus, N. | Hrašćan, R.

69

The Impact of Lateral Ventricular Opening in the Resection of Newly Diagnosed High-Grade Gliomas : A Single Center Experience

enthalten in: Cancers | 2024

von Cofano, F. | Bianconi, A. | De Marco, R. | +12

70

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma : A Safety and Preliminary Efficacy Trial of Pembrolizumab (MK-3475) in Children With Recurrent, Progressive or Refractory Diffuse Intrinsic Pontine Glioma (DIPG), Non-Brainstem High-Grade Gliomas (NB-HGG), Ependymoma, Medulloblastoma or Hypermutated Brain Tumors

enthalten in: ClinicalTrials.gov | 2024